characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Oxolinic acid, concentration 2.5 uM, experiment LM1844, well H8, technical replicate 2

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


status: PUBLIC

tag: attribute

characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Oxolinic acid, concentration 0.5 uM, experiment LM1844, well H9, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

characteristic: organism

text: Emergence of community behaviors in the gut microbiota upon drug treatment

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Ciprofloxacin, concentration 320 uM, experiment LM1844, well H10, technical replicate 2

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

text: synthetic metagenome

text: Sample treated with Ciprofloxacin, concentration 80 uM, experiment LM1844, well H11, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

text: public

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Ciprofloxacin, concentration 20 uM, experiment LM1844, well H12, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Acarbose, concentration 80 uM, experiment LM1847, well A1, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Acarbose, concentration 20 uM, experiment LM1847, well A2, technical replicate 1

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Acarbose, concentration 5 uM, experiment LM1847, well A3, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Lansoprazole, concentration 80 uM, experiment LM1847, well A4, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Lansoprazole, concentration 20 uM, experiment LM1847, well A5, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Lansoprazole, concentration 5 uM, experiment LM1847, well A6, technical replicate 1

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Acarbose, concentration 80 uM, experiment LM1847, well A7, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Acarbose, concentration 20 uM, experiment LM1847, well A8, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

text: synthetic metagenome

text: Sample treated with Acarbose, concentration 5 uM, experiment LM1847, well A9, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Lansoprazole, concentration 80 uM, experiment LM1847, well A10, technical replicate 2

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Lansoprazole, concentration 20 uM, experiment LM1847, well A11, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

text: synthetic metagenome

text: Sample treated with Lansoprazole, concentration 5 uM, experiment LM1847, well A12, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Clomiphene, concentration 80 uM, experiment LM1847, well B1, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Clomiphene, concentration 20 uM, experiment LM1847, well B2, technical replicate 1

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: Emergence of community behaviors in the gut microbiota upon drug treatment

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Clomiphene, concentration 5 uM, experiment LM1847, well B3, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Doxycycline, concentration 20 uM, experiment LM1847, well B4, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Doxycycline, concentration 2.5 uM, experiment LM1847, well B5, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Doxycycline, concentration 0.5 uM, experiment LM1847, well B6, technical replicate 1

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Clomiphene, concentration 80 uM, experiment LM1847, well B7, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Clomiphene, concentration 20 uM, experiment LM1847, well B8, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

text: synthetic metagenome

text: Sample treated with Clomiphene, concentration 5 uM, experiment LM1847, well B9, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Doxycycline, concentration 20 uM, experiment LM1847, well B10, technical replicate 2

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Doxycycline, concentration 2.5 uM, experiment LM1847, well B11, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

text: synthetic metagenome

text: Sample treated with Doxycycline, concentration 0.5 uM, experiment LM1847, well B12, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Ebselen, concentration 20 uM, experiment LM1847, well C1, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Ebselen, concentration 5 uM, experiment LM1847, well C2, technical replicate 1

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Ebselen, concentration 1.25 uM, experiment LM1847, well C3, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Ketoconazole, concentration 80 uM, experiment LM1847, well C4, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Ketoconazole, concentration 20 uM, experiment LM1847, well C5, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Ketoconazole, concentration 5 uM, experiment LM1847, well C6, technical replicate 1

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Ebselen, concentration 20 uM, experiment LM1847, well C7, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: Emergence of community behaviors in the gut microbiota upon drug treatment

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Ebselen, concentration 5 uM, experiment LM1847, well C8, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

text: synthetic metagenome

text: Sample treated with Ebselen, concentration 1.25 uM, experiment LM1847, well C9, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Ketoconazole, concentration 80 uM, experiment LM1847, well C10, technical replicate 2

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Ketoconazole, concentration 20 uM, experiment LM1847, well C11, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

text: synthetic metagenome

text: Sample treated with Ketoconazole, concentration 5 uM, experiment LM1847, well C12, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

text: synthetic metagenome

text: Control sample without drug, experiment LM1847, well D1, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Control sample without drug, experiment LM1847, well D2, technical replicate 1

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Control sample without drug, experiment LM1847, well D3, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Olanzapine, concentration 80 uM, experiment LM1847, well D4, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Olanzapine, concentration 20 uM, experiment LM1847, well D5, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Olanzapine, concentration 5 uM, experiment LM1847, well D6, technical replicate 1

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Control sample without drug, experiment LM1847, well D7, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

text: synthetic metagenome

text: Control sample without drug, experiment LM1847, well D8, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

text: synthetic metagenome

text: Control sample without drug, experiment LM1847, well D9, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Olanzapine, concentration 80 uM, experiment LM1847, well D10, technical replicate 2

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Olanzapine, concentration 20 uM, experiment LM1847, well D11, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

text: synthetic metagenome

text: Sample treated with Olanzapine, concentration 5 uM, experiment LM1847, well D12, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: Emergence of community behaviors in the gut microbiota upon drug treatment

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with beta-estradiol 17-valerate, concentration 80 uM, experiment LM1847, well E1, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with beta-estradiol 17-valerate, concentration 20 uM, experiment LM1847, well E2, technical replicate 1

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with beta-estradiol 17-valerate, concentration 5 uM, experiment LM1847, well E3, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Aripiprazole, concentration 80 uM, experiment LM1847, well E4, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Aripiprazole, concentration 20 uM, experiment LM1847, well E5, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Aripiprazole, concentration 5 uM, experiment LM1847, well E6, technical replicate 1

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with beta-estradiol 17-valerate, concentration 80 uM, experiment LM1847, well E7, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with beta-estradiol 17-valerate, concentration 20 uM, experiment LM1847, well E8, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

text: synthetic metagenome

text: Sample treated with beta-estradiol 17-valerate, concentration 5 uM, experiment LM1847, well E9, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Aripiprazole, concentration 80 uM, experiment LM1847, well E10, technical replicate 2

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Aripiprazole, concentration 20 uM, experiment LM1847, well E11, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

text: synthetic metagenome

text: Sample treated with Aripiprazole, concentration 5 uM, experiment LM1847, well E12, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Loxapine, concentration 80 uM, experiment LM1847, well F1, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Loxapine, concentration 20 uM, experiment LM1847, well F2, technical replicate 1

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Loxapine, concentration 5 uM, experiment LM1847, well F3, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Sertindole, concentration 80 uM, experiment LM1847, well F4, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Sertindole, concentration 20 uM, experiment LM1847, well F5, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

text: Emergence of community behaviors in the gut microbiota upon drug treatment

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Sertindole, concentration 5 uM, experiment LM1847, well F6, technical replicate 1

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Loxapine, concentration 80 uM, experiment LM1847, well F7, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Loxapine, concentration 20 uM, experiment LM1847, well F8, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

text: synthetic metagenome

text: Sample treated with Loxapine, concentration 5 uM, experiment LM1847, well F9, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Sertindole, concentration 80 uM, experiment LM1847, well F10, technical replicate 2

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Sertindole, concentration 20 uM, experiment LM1847, well F11, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

text: synthetic metagenome

text: Sample treated with Sertindole, concentration 5 uM, experiment LM1847, well F12, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Mefloquine, concentration 60 uM, experiment LM1847, well G1, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Mefloquine, concentration 20 uM, experiment LM1847, well G2, technical replicate 1

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Mefloquine, concentration 5 uM, experiment LM1847, well G3, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Chlorpromazine, concentration 80 uM, experiment LM1847, well G4, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Chlorpromazine, concentration 20 uM, experiment LM1847, well G5, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Chlorpromazine, concentration 5 uM, experiment LM1847, well G6, technical replicate 1

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Mefloquine, concentration 60 uM, experiment LM1847, well G7, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Mefloquine, concentration 20 uM, experiment LM1847, well G8, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

text: synthetic metagenome

text: Sample treated with Mefloquine, concentration 5 uM, experiment LM1847, well G9, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Chlorpromazine, concentration 80 uM, experiment LM1847, well G10, technical replicate 2

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: Emergence of community behaviors in the gut microbiota upon drug treatment

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Chlorpromazine, concentration 20 uM, experiment LM1847, well G11, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

text: synthetic metagenome

text: Sample treated with Chlorpromazine, concentration 5 uM, experiment LM1847, well G12, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Nifurtimox, concentration 35 uM, experiment LM1847, well H1, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Nifurtimox, concentration 20 uM, experiment LM1847, well H2, technical replicate 1

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Nifurtimox, concentration 2.5 uM, experiment LM1847, well H3, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Felodipine, concentration 80 uM, experiment LM1847, well H4, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Felodipine, concentration 20 uM, experiment LM1847, well H5, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Felodipine, concentration 5 uM, experiment LM1847, well H6, technical replicate 1

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Nifurtimox, concentration 35 uM, experiment LM1847, well H7, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Nifurtimox, concentration 20 uM, experiment LM1847, well H8, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

text: synthetic metagenome

text: Sample treated with Nifurtimox, concentration 2.5 uM, experiment LM1847, well H9, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Felodipine, concentration 80 uM, experiment LM1847, well H10, technical replicate 2

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Felodipine, concentration 20 uM, experiment LM1847, well H11, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

text: synthetic metagenome

text: Sample treated with Felodipine, concentration 5 uM, experiment LM1847, well H12, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Amlodipine, concentration 160 uM, experiment LM1847, well A1, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Amlodipine, concentration 80 uM, experiment LM1847, well A2, technical replicate 1

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Amlodipine, concentration 20 uM, experiment LM1847, well A3, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: Emergence of community behaviors in the gut microbiota upon drug treatment

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Diacerein, concentration 320 uM, experiment LM1847, well A4, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Diacerein, concentration 80 uM, experiment LM1847, well A5, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Diacerein, concentration 20 uM, experiment LM1847, well A6, technical replicate 1

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Amlodipine, concentration 160 uM, experiment LM1847, well A7, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Amlodipine, concentration 80 uM, experiment LM1847, well A8, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

text: synthetic metagenome

text: Sample treated with Amlodipine, concentration 20 uM, experiment LM1847, well A9, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Diacerein, concentration 320 uM, experiment LM1847, well A10, technical replicate 2

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Diacerein, concentration 80 uM, experiment LM1847, well A11, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

text: synthetic metagenome

text: Sample treated with Diacerein, concentration 20 uM, experiment LM1847, well A12, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Omeprazole, concentration 80 uM, experiment LM1847, well B1, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Omeprazole, concentration 20 uM, experiment LM1847, well B2, technical replicate 1

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Omeprazole, concentration 5 uM, experiment LM1847, well B3, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Tamoxifen, concentration 320 uM, experiment LM1847, well B4, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Tamoxifen, concentration 80 uM, experiment LM1847, well B5, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Tamoxifen, concentration 20 uM, experiment LM1847, well B6, technical replicate 1

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Omeprazole, concentration 80 uM, experiment LM1847, well B7, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Omeprazole, concentration 20 uM, experiment LM1847, well B8, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: Emergence of community behaviors in the gut microbiota upon drug treatment

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

text: synthetic metagenome

text: Sample treated with Omeprazole, concentration 5 uM, experiment LM1847, well B9, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Tamoxifen, concentration 320 uM, experiment LM1847, well B10, technical replicate 2

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Tamoxifen, concentration 80 uM, experiment LM1847, well B11, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

text: synthetic metagenome

text: Sample treated with Tamoxifen, concentration 20 uM, experiment LM1847, well B12, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Loratadine, concentration 80 uM, experiment LM1847, well C1, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Loratadine, concentration 20 uM, experiment LM1847, well C2, technical replicate 1

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Loratadine, concentration 5 uM, experiment LM1847, well C3, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Methotrexate, concentration 80 uM, experiment LM1847, well C4, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Methotrexate, concentration 20 uM, experiment LM1847, well C5, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Methotrexate, concentration 5 uM, experiment LM1847, well C6, technical replicate 1

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Loratadine, concentration 80 uM, experiment LM1847, well C7, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Loratadine, concentration 20 uM, experiment LM1847, well C8, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

text: synthetic metagenome

text: Sample treated with Loratadine, concentration 5 uM, experiment LM1847, well C9, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Methotrexate, concentration 80 uM, experiment LM1847, well C10, technical replicate 2

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Methotrexate, concentration 20 uM, experiment LM1847, well C11, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

text: synthetic metagenome

text: Sample treated with Methotrexate, concentration 5 uM, experiment LM1847, well C12, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

text: synthetic metagenome

text: Control sample without drug, experiment LM1847, well D1, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

text: Emergence of community behaviors in the gut microbiota upon drug treatment

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Control sample without drug, experiment LM1847, well D2, technical replicate 1

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Control sample without drug, experiment LM1847, well D3, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Dienestrol, concentration 80 uM, experiment LM1847, well D4, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Dienestrol, concentration 20 uM, experiment LM1847, well D5, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Dienestrol, concentration 5 uM, experiment LM1847, well D6, technical replicate 1

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Control sample without drug, experiment LM1847, well D7, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

text: synthetic metagenome

text: Control sample without drug, experiment LM1847, well D8, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

text: synthetic metagenome

text: Control sample without drug, experiment LM1847, well D9, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Dienestrol, concentration 80 uM, experiment LM1847, well D10, technical replicate 2

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Dienestrol, concentration 20 uM, experiment LM1847, well D11, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

text: synthetic metagenome

text: Sample treated with Dienestrol, concentration 5 uM, experiment LM1847, well D12, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Aprepitant, concentration 30 uM, experiment LM1847, well E1, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Aprepitant, concentration 20 uM, experiment LM1847, well E2, technical replicate 1

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Aprepitant, concentration 5 uM, experiment LM1847, well E3, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Niclosamide, concentration 160 uM, experiment LM1847, well E4, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Niclosamide, concentration 80 uM, experiment LM1847, well E5, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Niclosamide, concentration 20 uM, experiment LM1847, well E6, technical replicate 1

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: Emergence of community behaviors in the gut microbiota upon drug treatment

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Aprepitant, concentration 30 uM, experiment LM1847, well E7, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Aprepitant, concentration 20 uM, experiment LM1847, well E8, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

text: synthetic metagenome

text: Sample treated with Aprepitant, concentration 5 uM, experiment LM1847, well E9, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Niclosamide, concentration 160 uM, experiment LM1847, well E10, technical replicate 2

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Niclosamide, concentration 80 uM, experiment LM1847, well E11, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

text: public

text: synthetic metagenome

text: Sample treated with Niclosamide, concentration 20 uM, experiment LM1847, well E12, technical replicate 2

text: Synthetic gut microbial community

text: Synthetic gut microbial community

characteristic: environment (feature)

text: Synthetic gut microbial community

characteristic: environment (material)

text: Germany

characteristic: geographic location (country and/or sea)

text: amplicon sequencing

characteristic: investigation type

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


characteristic: ENA-CHECKLIST

characteristic: ENA-FIRST-PUBLIC

text: EMBL

text: public

text: synthetic metagenome

text: Sample treated with Entacapone, concentration 80 uM, experiment LM1847, well F1, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

characteristic: organism

characteristic: project name

text: synthetic metagenome

text: Illumina

characteristic: sequencing method

characteristic: title


characteristic: ENA-LAST-UPDATE

characteristic: External Id

text: EMBL

text: public

characteristic: collection date

text: synthetic metagenome

characteristic: common name

text: Sample treated with Entacapone, concentration 20 uM, experiment LM1847, well F2, technical replicate 1

characteristic: description

text: Synthetic gut microbial community

characteristic: environment (biome)

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina


text: EMBL

characteristic: INSDC center name

characteristic: INSDC first public

characteristic: INSDC last update

text: public

characteristic: INSDC status

characteristic: SRA accession

characteristic: Submitter Id

text: synthetic metagenome

text: Sample treated with Entacapone, concentration 5 uM, experiment LM1847, well F3, technical replicate 1

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Synthetic gut microbial community

text: Germany

text: amplicon sequencing

text: synthetic metagenome

text: synthetic metagenome

text: Illumina